Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


3 Big Medtech Takeaways From US Midterms

Executive Summary

The balance of power will be shifting in Washington, DC, following the Nov. 6 US midterm elections, but that probably will not mean major changes for medtech policies. Here are some key takeaways from the election for device and diagnostics companies.


Related Content

Newly Elected Dems Will Defend Preexisting Conditions, May Fight Device Tax Repeal
US Midterms: Industry Loses Some Supporters In Congress, But Retains Many
Medicare Allows Use Of Hospital Outreach Lab Pay Data; Industry Applauds, But Still Sues
US Senators Question FDA's Pre-Cert Program Authority, Concerned About Safety
CMS Actively Looking For New Reimbursement Pathway For Innovative Devices
US House Panel Passes Bill To Bring More Transparency To Local Coverage Determination Process
How A Rapid, Well-Messaged US FDA Offense Is Driving Spectators To Their Feet And Twitter Accounts
US House Votes To Permanently Repeal Device Tax
Who Is Responsible? Congressional Cybersecurity Inquiry Reveals Manufacturer, Provider Rift
Labs, Test Makers Urge Congress To Pass Diagnostic Reforms





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts